<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 18 Jun 2026 08:40:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting</title>
   <link>http://www.streetinsider.com/Press+Releases/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</link>
   <description>
&lt;ul&gt;&lt;li&gt;&lt;em&gt;First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;&lt;br/&gt;VALENCIA, Calif., June  18, 2026  (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AVH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40239309</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting</title>
   <link>http://www.streetinsider.com/Press+Releases/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</link>
   <description>
&lt;ul&gt;&lt;li&gt;&lt;em&gt;First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;&lt;br/&gt;VALENCIA, Calif., June  18, 2026  (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AVH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40239309</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting</title>
   <link>http://www.streetinsider.com/Press+Releases/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</link>
   <description>
&lt;ul&gt;&lt;li&gt;&lt;em&gt;First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;&lt;br/&gt;VALENCIA, Calif., June  18, 2026  (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AVH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40239309</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting</title>
   <link>http://www.streetinsider.com/Press+Releases/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</link>
   <description>
&lt;ul&gt;&lt;li&gt;&lt;em&gt;First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;&lt;br/&gt;VALENCIA, Calif., June  18, 2026  (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AVH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40239309</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting</title>
   <link>http://www.streetinsider.com/Press+Releases/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</link>
   <description>
&lt;ul&gt;&lt;li&gt;&lt;em&gt;First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;&lt;br/&gt;VALENCIA, Calif., June  18, 2026  (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AVH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40239309</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</link>
   <description>
&lt;ul&gt;&lt;li&gt;&lt;em&gt;First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;&lt;br/&gt;VALENCIA, Calif., June  18, 2026  (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AVH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40239309</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</link>
   <description>
&lt;ul&gt;&lt;li&gt;&lt;em&gt;First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;&lt;br/&gt;VALENCIA, Calif., June  18, 2026  (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AVH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40239309</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</link>
   <description>
&lt;ul&gt;&lt;li&gt;&lt;em&gt;First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;&lt;br/&gt;VALENCIA, Calif., June  18, 2026  (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AVH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40239309</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</link>
   <description>
&lt;ul&gt;&lt;li&gt;&lt;em&gt;First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;&lt;br/&gt;VALENCIA, Calif., June  18, 2026  (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AVH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40239309</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</link>
   <description>
&lt;ul&gt;&lt;li&gt;&lt;em&gt;First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery patients&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;Findings presented at the British Burn Association Annual Meeting support the role of RECELL GO in standardizing preparation of RECELL® Spray-On Skin™ Cells and improving operating room workflow&lt;/em&gt;&lt;br/&gt;&lt;br/&gt;&lt;/li&gt;&lt;li&gt;&lt;em&gt;RECELL GO is CE-marked in Europe and the U.K. and recently received regulatory authorization in Australia and New Zealand&lt;/em&gt;&lt;br/&gt;&lt;/li&gt;&lt;/ul&gt;  &lt;p&gt;&lt;br/&gt;VALENCIA, Calif., June  18, 2026  (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced the presentation of new clinical data highlighting the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/AVITA+Medical+Highlights+First+U.K.+Clinical+Experience+with+RECELL+GO+at+British+Burn+Association+Annual+Meeting/26663399.html</guid>
   <pubDate>Thu, 18 Jun 2026 08:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50215875</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">AVH</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.40239309</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>Form  4          AVITA Medical, Inc.       For: Jun 12  Filed by: O&amp;apos;Toole David D</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+12++Filed+by%3A+O%26apos%3BToole+David+D/26641335.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26641335.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+12++Filed+by%3A+O%26apos%3BToole+David+D/26641335.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>Form  4          AVITA Medical, Inc.       For: Jun 12  Filed by: O&amp;apos;Toole David D</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+12++Filed+by%3A+O%26apos%3BToole+David+D/26641335.html</link>
   <description>si-local-file:///var/storage/secattach/20260612/26641335.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+12++Filed+by%3A+O%26apos%3BToole+David+D/26641335.html</guid>
   <pubDate>Fri, 12 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>Form  4          AVITA Medical, Inc.       For: Jun 09  Filed by: Woody Joseph Fralin</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+09++Filed+by%3A+Woody+Joseph+Fralin/26631391.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26631391.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+09++Filed+by%3A+Woody+Joseph+Fralin/26631391.html</guid>
   <pubDate>Wed, 10 Jun 2026 21:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>Form  4          AVITA Medical, Inc.       For: Jun 09  Filed by: Woody Joseph Fralin</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+09++Filed+by%3A+Woody+Joseph+Fralin/26631391.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26631391.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+09++Filed+by%3A+Woody+Joseph+Fralin/26631391.html</guid>
   <pubDate>Wed, 10 Jun 2026 21:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>Form  4          AVITA Medical, Inc.       For: Jun 09  Filed by: Woody Joseph Fralin</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+09++Filed+by%3A+Woody+Joseph+Fralin/26624528.html</link>
   <description>si-local-file:///var/storage/secattach/20260609/26624528.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+09++Filed+by%3A+Woody+Joseph+Fralin/26624528.html</guid>
   <pubDate>Tue, 09 Jun 2026 16:58:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>Form  4          AVITA Medical, Inc.       For: Jun 09  Filed by: Woody Joseph Fralin</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+09++Filed+by%3A+Woody+Joseph+Fralin/26624528.html</link>
   <description>si-local-file:///var/storage/secattach/20260609/26624528.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+09++Filed+by%3A+Woody+Joseph+Fralin/26624528.html</guid>
   <pubDate>Tue, 09 Jun 2026 16:58:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>Form  8-K        AVITA Medical, Inc.       For: Jun 05</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+05/26613731.html</link>
   <description>si-local-file:///var/storage/secattach/20260608/26613731.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+05/26613731.html</guid>
   <pubDate>Mon, 08 Jun 2026 06:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AVHHL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>Form  8-K        AVITA Medical, Inc.       For: Jun 05</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+05/26613731.html</link>
   <description>si-local-file:///var/storage/secattach/20260608/26613731.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+05/26613731.html</guid>
   <pubDate>Mon, 08 Jun 2026 06:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AVHHL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>Form  8-K        AVITA Medical, Inc.       For: Jun 05</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+05/26613731.html</link>
   <description>si-local-file:///var/storage/secattach/20260608/26613731.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+05/26613731.html</guid>
   <pubDate>Mon, 08 Jun 2026 06:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AVHHL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>Form  424B5      AVITA Medical, Inc.                  </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B5++++++AVITA+Medical%2C+Inc.++++++++++++++++++/26613736.html</link>
   <description>si-local-file:///var/storage/secattach/20260608/26613736.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B5++++++AVITA+Medical%2C+Inc.++++++++++++++++++/26613736.html</guid>
   <pubDate>Mon, 08 Jun 2026 06:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AVHHL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>Form  424B5      AVITA Medical, Inc.                  </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B5++++++AVITA+Medical%2C+Inc.++++++++++++++++++/26613736.html</link>
   <description>si-local-file:///var/storage/secattach/20260608/26613736.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B5++++++AVITA+Medical%2C+Inc.++++++++++++++++++/26613736.html</guid>
   <pubDate>Mon, 08 Jun 2026 06:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AVHHL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>Form  424B5      AVITA Medical, Inc.                  </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B5++++++AVITA+Medical%2C+Inc.++++++++++++++++++/26613736.html</link>
   <description>si-local-file:///var/storage/secattach/20260608/26613736.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B5++++++AVITA+Medical%2C+Inc.++++++++++++++++++/26613736.html</guid>
   <pubDate>Mon, 08 Jun 2026 06:01:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">AVHHL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>Form  4          AVITA Medical, Inc.       For: Jun 03  Filed by: Woody Joseph Fralin</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+03++Filed+by%3A+Woody+Joseph+Fralin/26612001.html</link>
   <description>si-local-file:///var/storage/secattach/20260605/26612001.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+03++Filed+by%3A+Woody+Joseph+Fralin/26612001.html</guid>
   <pubDate>Fri, 05 Jun 2026 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>Form  4          AVITA Medical, Inc.       For: Jun 03  Filed by: Woody Joseph Fralin</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+03++Filed+by%3A+Woody+Joseph+Fralin/26612001.html</link>
   <description>si-local-file:///var/storage/secattach/20260605/26612001.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+03++Filed+by%3A+Woody+Joseph+Fralin/26612001.html</guid>
   <pubDate>Fri, 05 Jun 2026 17:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
  <item>
   <title>Form  4          AVITA Medical, Inc.       For: Jun 03  Filed by: McNamara Robert</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+03++Filed+by%3A+McNamara+Robert/26607304.html</link>
   <description>si-local-file:///var/storage/secattach/20260604/26607304.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++AVITA+Medical%2C+Inc.+++++++For%3A+Jun+03++Filed+by%3A+McNamara+Robert/26607304.html</guid>
   <pubDate>Thu, 04 Jun 2026 19:39:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.47986936</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RCEL</category>
   	  </item>
 </channel>
</rss>
